The estimated Net Worth of Catherine Corrigan is at least $15.4 Million dollars as of 13 March 2024. Catherine Corrigan owns over 12,410 units of Exponent stock worth over $8,966,187 and over the last 12 years he sold EXPO stock worth over $3,852,581. In addition, he makes $2,607,550 as President, Chief Executive Officer, and Director at Exponent.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Catherine Corrigan EXPO stock SEC Form 4 insiders trading
Catherine has made over 21 trades of the Exponent stock since 2013, according to the Form 4 filled with the SEC. Most recently he exercised 12,410 units of EXPO stock worth $1,297,962 on 13 March 2024.
The largest trade he's ever made was exercising 17,512 units of Exponent stock on 11 March 2020 worth over $1,831,580. On average, Catherine trades about 2,672 units every 74 days since 2013. As of 13 March 2024 he still owns at least 85,727 units of Exponent stock.
You can see the complete history of Catherine Corrigan stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Catherine Corrigan biography
Dr. Catherine Ford Corrigan Ph.D. serves as President, Chief Executive Officer, Director of the Company. Dr. Corrigan joined the Company in 1996. She was promoted to Principal in the Biomechanics practice in 2002 and was appointed Group Vice President in May 2012. Dr. Corrigan was named President in July 2016. She was named Chief Executive Officer and elected to the Board of Directors in May 2018. Dr. Corrigan earned her Ph.D. (1996) in Medical Engineering and Medical Physics and M.S. (1992) in Mechanical Engineering from the Massachusetts Institute of Technology and her B.S. in Bioengineering from the University of Pennsylvania. Prior to joining Exponent, Dr. Corrigan was a researcher in the Orthopaedic Biomechanics Laboratory at Beth Israel Hospital and Harvard Medical School. The Company believes that Dr. Corrigan’s service as President and Chief Executive Officer of the Company, and extensive and unique experience with the operations of the Company, qualifies her to serve as a director of the Company. The Company also considered Dr. Corrigan’s prior experience on and contributions to the Board in connection with her nomination.
What is the salary of Catherine Corrigan?
As the President, Chief Executive Officer, and Director of Exponent, the total compensation of Catherine Corrigan at Exponent is $2,607,550. There are no executives at Exponent getting paid more.
How old is Catherine Corrigan?
Catherine Corrigan is 51, he's been the President, Chief Executive Officer, and Director of Exponent since 2018. There are 20 older and 3 younger executives at Exponent. The oldest executive at Exponent Inc. is Dr. Subbaiah V. Malladi, 74, who is the CTO & Principal Engineer.
Insiders trading at Exponent
Over the last 21 years, insiders at Exponent have traded over $73,571,565 worth of Exponent stock and bought 2,000 units worth $170,360 . The most active insiders traders include Paul R Johnston, Richard L Jr Schlenker, and John B Shoven. On average, Exponent executives and independent directors trade stock every 11 days with the average trade being worth of $675,547. The most recent stock trade was executed by Richard L Jr Schlenker on 31 July 2024, trading 40,662 units of EXPO stock currently worth $4,339,042.
What does Exponent do?
exponent is an engineering and scientific consulting firm providing solutions to complex problems. whether the firm investigates an incident that happened in the past, or assists with the development of a new product or service, exponent offers knowledge to assist its clients make informed, intelligent decisions. exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and business today. the firm's consultants analyze failures and accidents to determine their causes and provide answers to help prevent such problems. in addition, exponent evaluates human health and environmental concerns to find cost-effective solutions. exponent’s staff of approximately 900, located in 20 offices throughout the nation and 6 international offices, combines unparalleled technical expertise with the ability, when necessary, to focus this knowledge in extreme
What does Exponent's logo look like?
Complete history of Catherine Corrigan stock trades at Exponent
Exponent executives and stock owners
Exponent executives and other stock owners filed with the SEC include:
-
Catherine Corrigan,
President, Chief Executive Officer, Director -
Richard Schlenker,
Chief Financial Officer, Executive Vice President, Corporate Secretary -
Dr. Catherine Ford Corrigan,
Pres, CEO & Director -
Steven Murray,
Group Vice President -
Sally Shepard,
Chief Human Resource Officer -
Richard L. Schlenker Jr.,
Exec. VP, CFO & Corp. Sec. -
Harri Kytomaa,
Group Vice President -
Dr. Maureen T. F. Reitman Sc.D., F.S.P.E., P.E.,
Corp. VP - Polymers Science & Materials Chemistry, Principal Engineer and Practice Director -
Dr. Steven J. Murray,
Group VP & Principal Engineer -
Dr. Bradley A. James Ph.D., P.E., FASM,
Corp. VP, Principal Engineer & Practice Director- Materials & Corrosion Engineering -
John Shoven,
Lead Independent Director -
Debra Zumwalt,
Independent Director -
Karen Richardson,
Independent Director -
Carol Lindstrom,
Independent Director -
Paul Johnston,
Chairman of the Board -
George Brown,
Director -
Maureen Reitman,
Group Vice President -
Richard Reiss,
Group Vice President -
John Pye,
Group Vice President -
Brad James,
Group Vice President -
Robert Haddad,
Group Vice President -
Dr. Robert D. Caligiuri FASM, P.E., Ph.D.,
Corp. VP of Materials & Corrosion Engineering and Principal Engineer -
Sally B. Shepard,
Chief HR Officer -
Dr. Paul D. Boehm,
Corp. VP of Environmental & Health Sciences and Principal Scientist -
Dr. Robert D. Caligiuri,
Corp. VP of Materials & Corrosion Engineering and Principal Engineer -
Eric R. Anderson,
VP & Corp. Controller -
Dr. Subbaiah V. Malladi,
CTO & Principal Engineer -
Dr. Bernard Ross,
Co-Founder, Chairman Emeritus & Principal Engineer -
Stephen C Riggins,
Director -
John Osteraas,
Group Vice President -
Paul Boehm,
Group Vice President -
Robert D Caligiuri,
Group Vice President -
John Joseph Doyle,
Group Vice President -
Elizabeth L Anderson,
Group Vice President -
Subbaiah V Malladi,
Chief Technical Officer -
Leslie G Denend,
Director -
Robert C Lange,
Group Vice President -
John E Moalli,
Group -
Samuel H Armacost,
Director -
Jon R Katzenbach,
Director -
Mary B Cranston,
Director -
Michael R Gaulke,
President & CEO -
Barbara M Barrett,
Director -
Roger L Mccarthy,
Chairman, -
Charles A Jr Rau,
Corporate Vice President -
Larry W Anderson,
Group Vice President -
Edward J Keith,
Director -
Angela A Meyer,
Vice President Client Services -
Piotr D Moncarz,
Corporate Vice President -
Joseph Rakow,
Group Vice President -
Eric Guyer,
Group Vice Presient